Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ruling out novel H1N1 influenza virus infection with direct fluorescent antigen testing.

Literature DB >> 19681710

Ruling out novel H1N1 influenza virus infection with direct fluorescent antigen testing.

Nira R Pollock¹, Scott Duong, Annie Cheng, Linda L Han, Sandra Smole, James E Kirby.

Abstract

We evaluated the ability of direct fluorescent antigen (DFA) influenza tests to identify novel H1N1 influenza virus. DFA results were compared with polymerase chain reaction results. The negative predictive value of DFA testing was at least 96%. Therefore, when performed on specimens of adequate quality, DFA tests can effectively rule out infection due to novel H1N1 virus.

Entities: CellLine Chemical Disease Species

Mesh：

Substances：
Antigens, Viral

Year: 2009 PMID： 19681710 PMCID： PMC2768282 DOI： 10.1086/644502

Source DB: PubMed Journal: Clin Infect Dis ISSN： 1058-4838 Impact factor: 9.079

6 in total

Review 1. Role of the laboratory in diagnosis of influenza during seasonal epidemics and potential pandemics.

Authors: Martin Petric; Lorraine Comanor; Cathy A Petti
Journal: J Infect Dis Date: 2006-11-01 Impact factor: 5.226

2. Comparison of the NOW Influenza A & B, NOW Flu A, NOW Flu B, and Directigen Flu A+B assays, and immunofluorescence with viral culture for the detection of influenza A and B viruses.

Authors: Marita Smit; Kirsten A Beynon; David R Murdoch; Lance C Jennings
Journal: Diagn Microbiol Infect Dis Date: 2007-01 Impact factor: 2.803

3. Suboptimal detection of influenza virus in adults by the Directigen Flu A+B enzyme immunoassay and correlation of results with the number of antigen-positive cells detected by cytospin immunofluorescence.

Authors: Marie L Landry; David Ferguson
Journal: J Clin Microbiol Date: 2003-07 Impact factor: 5.948

4. Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

Authors: Fatimah S Dawood; Seema Jain; Lyn Finelli; Michael W Shaw; Stephen Lindstrom; Rebecca J Garten; Larisa V Gubareva; Xiyan Xu; Carolyn B Bridges; Timothy M Uyeki
Journal: N Engl J Med Date: 2009-05-07 Impact factor: 91.245

5. Comparison of SmartCycler real-time reverse transcription-PCR assay in a public health laboratory with direct immunofluorescence and cell culture assays in a medical center for detection of influenza A virus.

Authors: Nadia F Habib-Bein; William H Beckwith; Donald Mayo; Marie L Landry
Journal: J Clin Microbiol Date: 2003-08 Impact factor: 5.948

6. Near-patient assays for diagnosis of influenza virus infection in adult patients.

Authors: C Steininger; M Redlberger; W Graninger; M Kundi; T Popow-Kraupp
Journal: Clin Microbiol Infect Date: 2009-01-29 Impact factor: 8.067

6 in total

20 in total

9. Cytospin-enhanced immunofluorescence and impact of sample quality on detection of novel swine origin (H1N1) influenza virus.

Authors: Marie L Landry; David Ferguson
Journal: J Clin Microbiol Date: 2009-12-30 Impact factor: 5.948

Review 10. Clinical review: primary influenza viral pneumonia.

Authors: Jordi Rello; Aurora Pop-Vicas
Journal: Crit Care Date: 2009-12-21 Impact factor: 9.097

Ruling out novel H1N1 influenza virus infection with direct fluorescent antigen testing.

Review 1. Role of the laboratory in diagnosis of influenza during seasonal epidemics and potential pandemics.

2. Comparison of the NOW Influenza A & B, NOW Flu A, NOW Flu B, and Directigen Flu A+B assays, and immunofluorescence with viral culture for the detection of influenza A and B viruses.

3. Suboptimal detection of influenza virus in adults by the Directigen Flu A+B enzyme immunoassay and correlation of results with the number of antigen-positive cells detected by cytospin immunofluorescence.

4. Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

5. Comparison of SmartCycler real-time reverse transcription-PCR assay in a public health laboratory with direct immunofluorescence and cell culture assays in a medical center for detection of influenza A virus.

6. Near-patient assays for diagnosis of influenza virus infection in adult patients.

1. Evaluation of diagnostic applications of monoclonal antibodies against avian influenza H7 viruses.

2. Direct fluorescent-antibody testing followed by culture for diagnosis of 2009 H1N1 influenza A.

3. Public hospital-based laboratory experience during an outbreak of pandemic influenza A (H1N1) virus infections.

4. Infections in hemodialysis: a concise review - Part 1: bacteremia and respiratory infections.

5. Understanding the Influenza A H1N1 2009 Pandemic.

6. Role of rapid immunochromatographic antigen testing in diagnosis of influenza A virus 2009 H1N1 infection.

7. Comparison of Xpert Flu rapid nucleic acid testing with rapid antigen testing for the diagnosis of influenza A and B.

8. Rapid antigen test for pandemic (H1N1) 2009 virus.

9. Cytospin-enhanced immunofluorescence and impact of sample quality on detection of novel swine origin (H1N1) influenza virus.

Review 10. Clinical review: primary influenza viral pneumonia.